nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Nucleoside Analog—Azathioprine—systemic lupus erythematosus	0.809	1	CiPCiCtD
Valganciclovir—SLC15A2—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0132	0.301	CbGpPWpGaD
Valganciclovir—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0122	0.279	CbGpPWpGaD
Valganciclovir—SLC15A2—choroid plexus—systemic lupus erythematosus	0.0101	0.548	CbGeAlD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00375	0.0856	CbGpPWpGaD
Valganciclovir—SLC6A14—lung—systemic lupus erythematosus	0.00287	0.156	CbGeAlD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00221	0.0504	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00177	0.0405	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00164	0.0376	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.00138	0.0315	CbGpPWpGaD
Valganciclovir—SLC15A1—nephron tubule—systemic lupus erythematosus	0.00116	0.0631	CbGeAlD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.00115	0.0264	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00104	0.0238	CbGpPWpGaD
Valganciclovir—SLC15A1—kidney—systemic lupus erythematosus	0.00102	0.0555	CbGeAlD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000986	0.0225	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.000968	0.0221	CbGpPWpGaD
Valganciclovir—SLC15A2—nephron tubule—systemic lupus erythematosus	0.000727	0.0395	CbGeAlD
Valganciclovir—SLC15A2—kidney—systemic lupus erythematosus	0.000639	0.0347	CbGeAlD
Valganciclovir—SLC15A2—cortex of kidney—systemic lupus erythematosus	0.000622	0.0338	CbGeAlD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000501	0.0114	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000466	0.0107	CbGpPWpGaD
Valganciclovir—SLC15A2—lung—systemic lupus erythematosus	0.000453	0.0246	CbGeAlD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	0.000449	0.0103	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000433	0.00989	CbGpPWpGaD
Valganciclovir—SLC15A2—nervous system—systemic lupus erythematosus	0.000419	0.0228	CbGeAlD
Valganciclovir—SLC15A2—central nervous system—systemic lupus erythematosus	0.000404	0.0219	CbGeAlD
Valganciclovir—SLC6A14—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000398	0.0091	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000237	0.00541	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00022	0.00503	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB1—systemic lupus erythematosus	0.000143	0.00327	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000142	0.00326	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000127	0.00291	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.24e-05	0.00165	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.74e-05	0.00154	CbGpPWpGaD
Valganciclovir—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	6.65e-05	0.000517	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000517	CcSEcCtD
Valganciclovir—Hypotension—Methylprednisolone—systemic lupus erythematosus	6.63e-05	0.000516	CcSEcCtD
Valganciclovir—Pain—Prednisolone—systemic lupus erythematosus	6.61e-05	0.000514	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—systemic lupus erythematosus	6.61e-05	0.000514	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—systemic lupus erythematosus	6.61e-05	0.000514	CcSEcCtD
Valganciclovir—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	6.59e-05	0.000512	CcSEcCtD
Valganciclovir—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.57e-05	0.000511	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—systemic lupus erythematosus	6.56e-05	0.00051	CcSEcCtD
Valganciclovir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.55e-05	0.00051	CcSEcCtD
Valganciclovir—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.55e-05	0.00051	CcSEcCtD
Valganciclovir—Nausea—Leflunomide—systemic lupus erythematosus	6.54e-05	0.000509	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	6.53e-05	0.000508	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	6.52e-05	0.000507	CcSEcCtD
Valganciclovir—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.51e-05	0.000506	CcSEcCtD
Valganciclovir—Vision blurred—Prednisone—systemic lupus erythematosus	6.49e-05	0.000505	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—systemic lupus erythematosus	6.48e-05	0.000504	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	6.48e-05	0.000504	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	6.46e-05	0.000503	CcSEcCtD
Valganciclovir—Pain—Hydrocortisone—systemic lupus erythematosus	6.46e-05	0.000502	CcSEcCtD
Valganciclovir—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	6.45e-05	0.000502	CcSEcCtD
Valganciclovir—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.45e-05	0.000502	CcSEcCtD
Valganciclovir—Oedema—Betamethasone—systemic lupus erythematosus	6.45e-05	0.000502	CcSEcCtD
Valganciclovir—Oedema—Dexamethasone—systemic lupus erythematosus	6.45e-05	0.000502	CcSEcCtD
Valganciclovir—Insomnia—Triamcinolone—systemic lupus erythematosus	6.43e-05	0.0005	CcSEcCtD
Valganciclovir—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.42e-05	0.000499	CcSEcCtD
Valganciclovir—Infection—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000499	CcSEcCtD
Valganciclovir—Infection—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000499	CcSEcCtD
Valganciclovir—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.39e-05	0.000497	CcSEcCtD
Valganciclovir—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.39e-05	0.000497	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.37e-05	0.000496	CcSEcCtD
Valganciclovir—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.37e-05	0.000496	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—systemic lupus erythematosus	6.37e-05	0.000495	CcSEcCtD
Valganciclovir—Anaemia—Prednisone—systemic lupus erythematosus	6.36e-05	0.000495	CcSEcCtD
Valganciclovir—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.34e-05	0.000493	CcSEcCtD
Valganciclovir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	6.33e-05	0.000492	CcSEcCtD
Valganciclovir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	6.33e-05	0.000492	CcSEcCtD
Valganciclovir—Agitation—Prednisone—systemic lupus erythematosus	6.33e-05	0.000492	CcSEcCtD
Valganciclovir—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.32e-05	0.000491	CcSEcCtD
Valganciclovir—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.32e-05	0.000491	CcSEcCtD
Valganciclovir—Tachycardia—Dexamethasone—systemic lupus erythematosus	6.3e-05	0.00049	CcSEcCtD
Valganciclovir—Tachycardia—Betamethasone—systemic lupus erythematosus	6.3e-05	0.00049	CcSEcCtD
Valganciclovir—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.26e-05	0.000487	CcSEcCtD
Valganciclovir—Dyspepsia—Triamcinolone—systemic lupus erythematosus	6.26e-05	0.000487	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.25e-05	0.00143	CbGpPWpGaD
Valganciclovir—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	6.25e-05	0.000486	CcSEcCtD
Valganciclovir—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	6.24e-05	0.000485	CcSEcCtD
Valganciclovir—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	6.24e-05	0.000485	CcSEcCtD
Valganciclovir—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.22e-05	0.000484	CcSEcCtD
Valganciclovir—Malaise—Prednisone—systemic lupus erythematosus	6.21e-05	0.000483	CcSEcCtD
Valganciclovir—Vertigo—Prednisone—systemic lupus erythematosus	6.19e-05	0.000481	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—systemic lupus erythematosus	6.18e-05	0.00048	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.18e-05	0.00048	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—systemic lupus erythematosus	6.16e-05	0.000479	CcSEcCtD
Valganciclovir—Anorexia—Dexamethasone—systemic lupus erythematosus	6.15e-05	0.000478	CcSEcCtD
Valganciclovir—Anorexia—Betamethasone—systemic lupus erythematosus	6.15e-05	0.000478	CcSEcCtD
Valganciclovir—Urticaria—Prednisolone—systemic lupus erythematosus	6.14e-05	0.000478	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.13e-05	0.000477	CcSEcCtD
Valganciclovir—Fatigue—Triamcinolone—systemic lupus erythematosus	6.13e-05	0.000477	CcSEcCtD
Valganciclovir—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.12e-05	0.000476	CcSEcCtD
Valganciclovir—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.11e-05	0.000475	CcSEcCtD
Valganciclovir—Asthenia—Cyclosporine—systemic lupus erythematosus	6.1e-05	0.000474	CcSEcCtD
Valganciclovir—Pain—Triamcinolone—systemic lupus erythematosus	6.08e-05	0.000473	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.03e-05	0.00138	CbGpPWpGaD
Valganciclovir—Hypotension—Dexamethasone—systemic lupus erythematosus	6.03e-05	0.000469	CcSEcCtD
Valganciclovir—Hypotension—Betamethasone—systemic lupus erythematosus	6.03e-05	0.000469	CcSEcCtD
Valganciclovir—Pruritus—Cyclosporine—systemic lupus erythematosus	6.01e-05	0.000468	CcSEcCtD
Valganciclovir—Urticaria—Hydrocortisone—systemic lupus erythematosus	6e-05	0.000467	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—systemic lupus erythematosus	6e-05	0.000466	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—systemic lupus erythematosus	5.97e-05	0.000464	CcSEcCtD
Valganciclovir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.97e-05	0.000464	CcSEcCtD
Valganciclovir—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.97e-05	0.000464	CcSEcCtD
Valganciclovir—Convulsion—Prednisone—systemic lupus erythematosus	5.97e-05	0.000464	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	5.96e-05	0.000463	CcSEcCtD
Valganciclovir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.95e-05	0.000463	CcSEcCtD
Valganciclovir—Hypertension—Prednisone—systemic lupus erythematosus	5.94e-05	0.000462	CcSEcCtD
Valganciclovir—Chills—Methotrexate—systemic lupus erythematosus	5.93e-05	0.000461	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5.88e-05	0.000457	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5.88e-05	0.000457	CcSEcCtD
Valganciclovir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.87e-05	0.000456	CcSEcCtD
Valganciclovir—Arthralgia—Prednisone—systemic lupus erythematosus	5.86e-05	0.000456	CcSEcCtD
Valganciclovir—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.86e-05	0.000456	CcSEcCtD
Valganciclovir—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.85e-05	0.000455	CcSEcCtD
Valganciclovir—Anxiety—Prednisone—systemic lupus erythematosus	5.84e-05	0.000454	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—systemic lupus erythematosus	5.84e-05	0.000454	CcSEcCtD
Valganciclovir—Insomnia—Dexamethasone—systemic lupus erythematosus	5.84e-05	0.000454	CcSEcCtD
Valganciclovir—Insomnia—Betamethasone—systemic lupus erythematosus	5.84e-05	0.000454	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	5.82e-05	0.000453	CcSEcCtD
Valganciclovir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.81e-05	0.000452	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.8e-05	0.000451	CcSEcCtD
Valganciclovir—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.79e-05	0.000451	CcSEcCtD
Valganciclovir—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.79e-05	0.000451	CcSEcCtD
Valganciclovir—Discomfort—Prednisone—systemic lupus erythematosus	5.79e-05	0.00045	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—systemic lupus erythematosus	5.79e-05	0.00045	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—systemic lupus erythematosus	5.75e-05	0.000448	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.7e-05	0.000443	CcSEcCtD
Valganciclovir—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.68e-05	0.000442	CcSEcCtD
Valganciclovir—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.68e-05	0.000442	CcSEcCtD
Valganciclovir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.67e-05	0.000441	CcSEcCtD
Valganciclovir—Urticaria—Triamcinolone—systemic lupus erythematosus	5.65e-05	0.000439	CcSEcCtD
Valganciclovir—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.64e-05	0.000438	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000438	CcSEcCtD
Valganciclovir—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.62e-05	0.000437	CcSEcCtD
Valganciclovir—Dizziness—Cyclosporine—systemic lupus erythematosus	5.62e-05	0.000437	CcSEcCtD
Valganciclovir—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.62e-05	0.000437	CcSEcCtD
Valganciclovir—Oedema—Prednisone—systemic lupus erythematosus	5.62e-05	0.000437	CcSEcCtD
Valganciclovir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.61e-05	0.000436	CcSEcCtD
Valganciclovir—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.61e-05	0.000436	CcSEcCtD
Valganciclovir—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.61e-05	0.000436	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.6e-05	0.00128	CbGpPWpGaD
Valganciclovir—Infection—Prednisone—systemic lupus erythematosus	5.58e-05	0.000434	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.57e-05	0.000433	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.57e-05	0.000433	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—systemic lupus erythematosus	5.57e-05	0.000433	CcSEcCtD
Valganciclovir—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.56e-05	0.000433	CcSEcCtD
Valganciclovir—Fatigue—Dexamethasone—systemic lupus erythematosus	5.56e-05	0.000433	CcSEcCtD
Valganciclovir—Fatigue—Betamethasone—systemic lupus erythematosus	5.56e-05	0.000433	CcSEcCtD
Valganciclovir—Pain—Dexamethasone—systemic lupus erythematosus	5.52e-05	0.000429	CcSEcCtD
Valganciclovir—Pain—Betamethasone—systemic lupus erythematosus	5.52e-05	0.000429	CcSEcCtD
Valganciclovir—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.51e-05	0.000429	CcSEcCtD
Valganciclovir—Tachycardia—Prednisone—systemic lupus erythematosus	5.48e-05	0.000427	CcSEcCtD
Valganciclovir—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.48e-05	0.000426	CcSEcCtD
Valganciclovir—Skin disorder—Prednisone—systemic lupus erythematosus	5.46e-05	0.000425	CcSEcCtD
Valganciclovir—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.43e-05	0.000423	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000422	CcSEcCtD
Valganciclovir—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.42e-05	0.000421	CcSEcCtD
Valganciclovir—Vomiting—Cyclosporine—systemic lupus erythematosus	5.4e-05	0.00042	CcSEcCtD
Valganciclovir—Anorexia—Prednisone—systemic lupus erythematosus	5.36e-05	0.000417	CcSEcCtD
Valganciclovir—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.35e-05	0.000416	CcSEcCtD
Valganciclovir—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.34e-05	0.000416	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000415	CcSEcCtD
Valganciclovir—Headache—Cyclosporine—systemic lupus erythematosus	5.32e-05	0.000414	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000414	CcSEcCtD
Valganciclovir—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.32e-05	0.000414	CcSEcCtD
Valganciclovir—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.32e-05	0.000414	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.28e-05	0.00041	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.28e-05	0.00041	CcSEcCtD
Valganciclovir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.27e-05	0.00041	CcSEcCtD
Valganciclovir—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.24e-05	0.000408	CcSEcCtD
Valganciclovir—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.23e-05	0.000407	CcSEcCtD
Valganciclovir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.22e-05	0.000406	CcSEcCtD
Valganciclovir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000404	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—systemic lupus erythematosus	5.19e-05	0.000404	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—systemic lupus erythematosus	5.17e-05	0.000402	CcSEcCtD
Valganciclovir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.17e-05	0.000402	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—systemic lupus erythematosus	5.15e-05	0.000401	CcSEcCtD
Valganciclovir—Urticaria—Dexamethasone—systemic lupus erythematosus	5.13e-05	0.000399	CcSEcCtD
Valganciclovir—Urticaria—Betamethasone—systemic lupus erythematosus	5.13e-05	0.000399	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.12e-05	0.000398	CcSEcCtD
Valganciclovir—Dizziness—Prednisolone—systemic lupus erythematosus	5.11e-05	0.000398	CcSEcCtD
Valganciclovir—Asthenia—Triamcinolone—systemic lupus erythematosus	5.1e-05	0.000397	CcSEcCtD
Valganciclovir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.1e-05	0.000397	CcSEcCtD
Valganciclovir—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.1e-05	0.000397	CcSEcCtD
Valganciclovir—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.1e-05	0.000397	CcSEcCtD
Valganciclovir—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.1e-05	0.000397	CcSEcCtD
Valganciclovir—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.09e-05	0.000396	CcSEcCtD
Valganciclovir—Insomnia—Prednisone—systemic lupus erythematosus	5.08e-05	0.000395	CcSEcCtD
Valganciclovir—Nausea—Cyclosporine—systemic lupus erythematosus	5.05e-05	0.000393	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisone—systemic lupus erythematosus	5.05e-05	0.000392	CcSEcCtD
Valganciclovir—Pruritus—Triamcinolone—systemic lupus erythematosus	5.03e-05	0.000391	CcSEcCtD
Valganciclovir—Cough—Methotrexate—systemic lupus erythematosus	5.02e-05	0.000391	CcSEcCtD
Valganciclovir—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.02e-05	0.00039	CcSEcCtD
Valganciclovir—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.99e-05	0.000388	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000388	CcSEcCtD
Valganciclovir—Dyspepsia—Prednisone—systemic lupus erythematosus	4.95e-05	0.000385	CcSEcCtD
Valganciclovir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.92e-05	0.000383	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—systemic lupus erythematosus	4.9e-05	0.000381	CcSEcCtD
Valganciclovir—Decreased appetite—Prednisone—systemic lupus erythematosus	4.88e-05	0.00038	CcSEcCtD
Valganciclovir—Dermatitis—Prednisolone—systemic lupus erythematosus	4.87e-05	0.000379	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000378	CcSEcCtD
Valganciclovir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.85e-05	0.000378	CcSEcCtD
Valganciclovir—Fatigue—Prednisone—systemic lupus erythematosus	4.84e-05	0.000377	CcSEcCtD
Valganciclovir—Headache—Prednisolone—systemic lupus erythematosus	4.84e-05	0.000377	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—systemic lupus erythematosus	4.84e-05	0.000376	CcSEcCtD
Valganciclovir—Constipation—Prednisone—systemic lupus erythematosus	4.81e-05	0.000374	CcSEcCtD
Valganciclovir—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.8e-05	0.000373	CcSEcCtD
Valganciclovir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.76e-05	0.00037	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000368	CcSEcCtD
Valganciclovir—Headache—Hydrocortisone—systemic lupus erythematosus	4.73e-05	0.000368	CcSEcCtD
Valganciclovir—Dizziness—Triamcinolone—systemic lupus erythematosus	4.7e-05	0.000366	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000365	CcSEcCtD
Valganciclovir—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.69e-05	0.000365	CcSEcCtD
Valganciclovir—Infection—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000363	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.63e-05	0.00036	CcSEcCtD
Valganciclovir—Asthenia—Betamethasone—systemic lupus erythematosus	4.63e-05	0.00036	CcSEcCtD
Valganciclovir—Asthenia—Dexamethasone—systemic lupus erythematosus	4.63e-05	0.00036	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000358	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.6e-05	0.000358	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.6e-05	0.000357	CcSEcCtD
Valganciclovir—Nausea—Prednisolone—systemic lupus erythematosus	4.59e-05	0.000357	CcSEcCtD
Valganciclovir—Pruritus—Betamethasone—systemic lupus erythematosus	4.57e-05	0.000355	CcSEcCtD
Valganciclovir—Pruritus—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.000355	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000355	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.54e-05	0.000353	CcSEcCtD
Valganciclovir—Vomiting—Triamcinolone—systemic lupus erythematosus	4.52e-05	0.000352	CcSEcCtD
Valganciclovir—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.51e-05	0.000351	CcSEcCtD
Valganciclovir—Nausea—Hydrocortisone—systemic lupus erythematosus	4.49e-05	0.000349	CcSEcCtD
Valganciclovir—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.48e-05	0.000348	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000348	CcSEcCtD
Valganciclovir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.47e-05	0.000348	CcSEcCtD
Valganciclovir—Urticaria—Prednisone—systemic lupus erythematosus	4.46e-05	0.000347	CcSEcCtD
Valganciclovir—Headache—Triamcinolone—systemic lupus erythematosus	4.46e-05	0.000347	CcSEcCtD
Valganciclovir—Headache—Methylprednisolone—systemic lupus erythematosus	4.45e-05	0.000346	CcSEcCtD
Valganciclovir—Abdominal pain—Prednisone—systemic lupus erythematosus	4.44e-05	0.000346	CcSEcCtD
Valganciclovir—Body temperature increased—Prednisone—systemic lupus erythematosus	4.44e-05	0.000346	CcSEcCtD
Valganciclovir—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000343	CcSEcCtD
Valganciclovir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000343	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—systemic lupus erythematosus	4.39e-05	0.000341	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000333	CcSEcCtD
Valganciclovir—Dizziness—Dexamethasone—systemic lupus erythematosus	4.27e-05	0.000332	CcSEcCtD
Valganciclovir—Dizziness—Betamethasone—systemic lupus erythematosus	4.27e-05	0.000332	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—systemic lupus erythematosus	4.25e-05	0.00033	CcSEcCtD
Valganciclovir—Nausea—Triamcinolone—systemic lupus erythematosus	4.22e-05	0.000329	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000328	CcSEcCtD
Valganciclovir—Nausea—Methylprednisolone—systemic lupus erythematosus	4.21e-05	0.000328	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000326	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000325	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.14e-05	0.000322	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.13e-05	0.000322	CcSEcCtD
Valganciclovir—Vomiting—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000319	CcSEcCtD
Valganciclovir—Vomiting—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000319	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.08e-05	0.000318	CcSEcCtD
Valganciclovir—Dermatitis—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000316	CcSEcCtD
Valganciclovir—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000316	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.05e-05	0.000315	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—systemic lupus erythematosus	4.05e-05	0.000315	CcSEcCtD
Valganciclovir—Headache—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000314	CcSEcCtD
Valganciclovir—Headache—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000314	CcSEcCtD
Valganciclovir—Asthenia—Prednisone—systemic lupus erythematosus	4.03e-05	0.000314	CcSEcCtD
Valganciclovir—Pain—Methotrexate—systemic lupus erythematosus	4.02e-05	0.000312	CcSEcCtD
Valganciclovir—Pruritus—Prednisone—systemic lupus erythematosus	3.98e-05	0.000309	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000301	CcSEcCtD
Valganciclovir—Diarrhoea—Prednisone—systemic lupus erythematosus	3.84e-05	0.000299	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000299	CcSEcCtD
Valganciclovir—Nausea—Betamethasone—systemic lupus erythematosus	3.83e-05	0.000298	CcSEcCtD
Valganciclovir—Nausea—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.000298	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—systemic lupus erythematosus	3.73e-05	0.00029	CcSEcCtD
Valganciclovir—Dizziness—Prednisone—systemic lupus erythematosus	3.72e-05	0.000289	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000289	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000289	CcSEcCtD
Valganciclovir—Vomiting—Prednisone—systemic lupus erythematosus	3.57e-05	0.000278	CcSEcCtD
Valganciclovir—Dermatitis—Prednisone—systemic lupus erythematosus	3.54e-05	0.000275	CcSEcCtD
Valganciclovir—Headache—Prednisone—systemic lupus erythematosus	3.52e-05	0.000274	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.46e-05	0.000269	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.42e-05	0.000782	CbGpPWpGaD
Valganciclovir—Asthenia—Methotrexate—systemic lupus erythematosus	3.37e-05	0.000262	CcSEcCtD
Valganciclovir—Nausea—Prednisone—systemic lupus erythematosus	3.34e-05	0.00026	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000258	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.21e-05	0.00025	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.18e-05	0.000726	CbGpPWpGaD
Valganciclovir—Dizziness—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000242	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000232	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—systemic lupus erythematosus	2.96e-05	0.00023	CcSEcCtD
Valganciclovir—Headache—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000229	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000217	CcSEcCtD
